World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
41004
World Ranking
7034
National Ranking
3696

Overview

David C. Dale is affiliated with the University of Washington in the United States. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader domains, the scientist has contributed notably to Genetics, Oncology, Immunology, Artificial Intelligence, and Hematology.

The main research topics addressed include blood disorders and treatments, neutropenia and cancer infections, immunodeficiency and autoimmune disorders, chemokine receptors and signaling, cell adhesion molecules research, natural language processing techniques, and topic modeling.

Among the recent scientific papers authored or co-authored by David C. Dale are the following:

  • "Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome" (2021), published in Nature Communications
  • "Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome" (2020), published in Blood
  • "The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action" (2023), published in HemaSphere
  • "Heterozygous variants of CLPB are a cause of severe congenital neutropenia" (2021), published in Blood
  • "ParaDetox: Detoxification with Parallel Data" (2022), published in the Proceedings of the 60th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers)

Frequent co-authors collaborating with David C. Dale include Audrey Anna Bolyard, Vahagn Makaryan, Merideth L. Kelley, Marta R. Costa-jussà, and Christophe Ropers.

The scientist regularly publishes in venues such as Blood, arXiv (Cornell University), HemaSphere, Supportive Care in Cancer, and Cancer Research.

Best Publications

  • The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

    Michael J. Chusid;David C. Dale;Burton C. West;Sheldon M. Wolff

  • Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

    Hal E. Broxmeyer;Christie M. Orschell;D. Wade Clapp;Giao Hangoc

  • Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations

    Anthony S. Fauci;David C. Dale;James E. Balow

  • The phagocytes: neutrophils and monocytes

    David C. Dale;Laurence Boxer;W. Conrad Liles

  • Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy : A systematic review

    Nicole M. Kuderer;David C. Dale;Jeffrey Crawford;Gary H. Lyman

  • Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.

    W. Conrad Liles;W. Conrad Liles;Hal E. Broxmeyer;Hal E. Broxmeyer;Elin Rodger;Elin Rodger;Brent Wood;Brent Wood

  • The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

    Anthony S. Fauci;David C. Dale

  • Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

    David C. Dale;Richard E. Person;Audrey Anna Bolyard;Andrew G. Aprikyan

  • Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis

    Marshall Horwitz;Kathleen F. Benson;Richard E. Person;Andrew G. Aprikyan

  • Incidence and Predictors of Low Dose-Intensity in Adjuvant Breast Cancer Chemotherapy: A Nationwide Study of Community Practices

    Gary H. Lyman;David C. Dale;Jeffrey Crawford

  • A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia

    DC Dale;MA Bonilla;MW Davis;AM Nakanishi

  • The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

    Philip S. Rosenberg;Blanche P. Alter;Audrey A. Bolyard;Mary Ann Bonilla

  • Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.

    David C. Dale;Tammy E. Cottle;Carol J. Fier;Audrey Anna Bolyard

  • Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.

    William P. Hammond;Thomas H. Price;Lawrence M. Souza;David C. Dale

  • Colchicine therapy for familial mediterranean fever. A double-blind trial.

    Charles A. Dinarello;Sheldon M. Wolff;Stephen E. Goldfinger;David C. Dale

  • The hypereosinophilic syndrome

    Michael J. Chusid;David C. Dale;Burton C. West;Sheldon M. Wolff

  • Wegener's Granulomatosis

    Sheldon M. Wolff;Anthony S. Fauci;Robert G. Horn;David C. Dale

  • Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

    Priya S. Kishnani;Stephanie L. Austin;Jose E. Abdenur;Pamela Arn

  • Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone.

    D C Dale;A S Fauci;S M Wolff

  • The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.

    WI Bensinger;TH Price;DC Dale;FR Appelbaum

Frequent Co-Authors

Gary H. Lyman
Gary H. Lyman Fred Hutchinson Cancer Research Center
Jeffrey Crawford
Jeffrey Crawford Duke University
Laurence A. Boxer
Laurence A. Boxer University of Michigan–Ann Arbor
Karl Welte
Karl Welte University of Tübingen
Daniel C. Link
Daniel C. Link Washington University in St. Louis
Sheldon M. Wolff
Sheldon M. Wolff Tufts Medical Center
Peter E. Newburger
Peter E. Newburger University of Massachusetts Chan Medical School
Akiko Shimamura
Akiko Shimamura Harvard University
W. Conrad Liles
W. Conrad Liles University of Washington
Blanche P. Alter
Blanche P. Alter National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD in the USA is a rewarding but challenging path. However, there are related healthcare degrees and career routes that offer faster entry or alternative professional roles. For instance, those seeking to join the workforce quickly might explore fast track lpn programs online, which equip students for licensed practical nursing positions in as little as one year.

For registered nurses aiming to advance their specialization, the shortest online pmhnp programs offer a streamlined option to become Psychiatric Mental Health Nurse Practitioners, meeting a growing demand for mental health professionals.

If you’re interested in leadership or administrative roles rather than direct patient care, consider a health administration degrees online program. These degrees prepare students for in-demand roles overseeing healthcare operations.

Professionals seeking higher managerial positions may also benefit from pursuing a master's in healthcare administration online. This advanced study opens doors to executive roles in hospitals and healthcare organizations.

Best Scientists Citing David C. Dale

Trending Scientists